Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v3-EN
Language French English
Date Updated 2019-03-06 2018-04-11
Drug Identification Number
Brand name CHOLETEC CHOLETEC
Common or Proper name MEBROFENIN powder MEBROFENIN powder
Company Name BRACCO IMAGING CANADA BRACCO IMAGING CANADA
Ingredients MEBROFENIN MEBROFENIN
Strength(s) 45 mg/vial 45 mg/vial
Dosage form(s) Powder for solution Powder for solution
Route of administration Intravenous Intravenous
Packaging size kits of 10 vials kits of 10 vials
ATC code V09DA V09DA
ATC description Hepatic and reticulo endothelial system Hepatic and reticulo endothelial system
Reason for shortage Disruption of the manufacture of the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-04-10 2018-04-10
Estimated end date 2019-04-01 2018-08-30
Actual end date 2019-03-05
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments The Canadian supply is re-established.
Health Canada comments